Using baseline MRI radiomics to predict the tumor shrinkage patterns in HR-Positive, HER2-Negative Breast Cancer
{{output}}
Introduction: This study aimed to develop and validate a predictive model for tumor shrinkage patterns in hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer patients undergoing neoadjuvant chemotherapy (NAC). ... ...
